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Objective: This study was undertaken to describe the combined measurement of
cerebral blood flow velocity and cerebral oxygen saturation as a guide to bypass
flow rate for regional low-flow perfusion during neonatal aortic arch reconstruction.
Methods: Data were prospectively collected from 34 patients undergoing neonatal
aortic arch reconstruction with regional low-flow perfusion. Cerebral oxygen satu-
ration and blood flow velocity were measured by near-infrared spectroscopy and
transcranial Doppler ultrasonography, respectively, throughout cardiopulmonary
bypass. After cooling to 17°C to 22°C, baseline values of cerebral oxygen saturation
and blood flow velocity were recorded during full-flow bypass. Regional low-flow
perfusion was instituted for aortic arch reconstruction, and bypass flow rate was
adjusted to maintain cerebral oxygen saturations and blood flow velocities within
10% of baseline recorded during cold full-flow bypass. Cerebral oxygen saturations
and blood flow velocities were recorded again after repair during full-flow hypo-
thermic bypass. Bypass flow during regional low-flow perfusion was recorded, as
were arterial pressure and blood gas data. One-way repeated measures analysis of
variance was used to determine differences in values during regional low-flow
perfusion relative to baseline and after perfusion.
Results: A mean bypass flow of 63 mL/(kg  min) was required to maintain
cerebral oxygen saturations and blood flow velocities within 10% of baseline. Mean
arterial pressure had a poor correlation with the required bypass flow rate (r2 
0.006 by linear regression analysis). Fourteen of 34 patients had a cerebral oxygen
saturation of 95% during regional low-flow perfusion, placing them at risk for
cerebral hyperperfusion if the cerebral oxygen saturation had been used alone to
guide bypass flow. Pressure was detected in the umbilical or femoral artery catheter
(mean 12 mm Hg) in all patients during regional low-flow perfusion.
Conclusions: Cerebral blood flow velocity, as determined by transcranial Doppler
ultrasonography, adds valuable information to cerebral oxygen saturation data in
guiding bypass flow during regional low-flow perfusion. Its most important use may
be prevention of cerebral hyperperfusion during periods with high near-infrared
spectroscopic saturation values.
Neonatal aortic arch reconstruction requires a bloodless operatingfield for optimum surgical precision. Traditionally this has beenperformed with deep hypothermic circulatory arrest (DHCA) forperiods as long as 60 minutes, or even longer for such complexprocedures as the Norwood operation for hypoplastic left heartsyndrome (HLHS). Recent clinical evidence has demonstrated
that periods of DHCA of 45 to 60 minutes or longer are associated with significant
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risk of neurologic injury.1,2 Cardiopulmonary bypass tech-
niques have been developed to minimize periods of
DHCA.3,4 One such technique is regional low-flow perfu-
sion (RLFP),5,6 in which only the brain and upper body are
perfused, allowing a bloodless field for aortic reconstruction
and either eliminating DHCA or limiting it to short periods.
Near-infrared spectroscopy (NIRS) measures the oxygen
saturation (SO2) of hemoglobin in the blood vessels of the
frontal cerebral cortex. It may provide an estimate of cere-
bral blood volume, the cerebral blood volume index
(CBVI), and functions under a wide variety of conditions,
including hypothermic cardiopulmonary bypass and DHCA
in infants and children.7,8 NIRS has been used to guide
bypass flow during RLFP, with the goal of matching CBVI
during RLFP to baseline CBVI on full bypass flow to the
whole body.6 Possible shortcomings of using NIRS alone
are that it is a trend monitor only. It does not measure
absolute SO2, and relative to jugular venous bulb-measured
SO2, it is less accurate at the high and low ends of the scale.9
Commercially available cerebral oximeters read a maxi-
mum high value of 95%, potentially exposing the patient to
the risk of cerebral hyperperfusion at high cerebral SO2
values. Finally, CBVI has not been independently validated
as a true measure of cerebral blood volume or blood flow.
Pulsed-wave transcranial Doppler ultrasonography
(TCD) is a sensitive indicator of cerebral blood flow (CBF)
velocity (CBFV).10 It has been used for neonatal heart
surgery to guide flow rate during low-flow bypass,11 as a
monitor of adequacy of arterial and venous bypass cannula
placement, and for the detection of cerebral emboli in in-
fants and children.12 The purpose of this study is to describe
the addition of CBFV, as measured by TCD, to cerebral
cortical SO2, as measured by NIRS, as a guide to bypass
flow during RLFP during neonatal aortic arch reconstruc-
tion.
Methods
After institutional review board approval was obtained, infants
undergoing aortic arch reconstruction were studied. Patients un-
dergoing the Norwood operation for HLHS or a variant and those
undergoing aortic arch advancement for interrupted aortic arch or
severe arch hypoplasia were studied if a period of RLFP was
planned.
The anesthetic technique consisted of high-dose fentanyl (100-
200 g/kg), midazolam (0.3-1.0 mg/kg), and pancuronium bro-
mide or vecuronium bromide for muscle relaxation. Low-dose
isoflurane (1%) was used to supplement the anesthetic before
bypass. Isoflurane at up to 2% was used on bypass for vasodilation
and was always discontinued before rewarming.
Arterial pressure monitoring consisted of an umbilical or fem-
oral arterial catheter. In addition, a catheter was placed in the left
radial or brachial artery for patients undergoing the Norwood
operation and in the right radial or brachial artery for patients
undergoing aortic arch advancement. Two arterial catheters were
used to monitor both the cerebral and distal aortic pressures during
RLFP and to assess the adequacy of repair after aortic arch
advancement.
Cerebral physiologic monitoring included NIRS (INVOS 5100;
Somanetics Corporation, Troy, Mich) to measure cerebral SO2.
This method uses near-infrared light at 730- and 810-nm wave-
lengths to measure the absorption spectra of oxyhemoglobin and
deoxyhemoglobin in the frontal cerebral cortex. A shallow detector
subtracts light absorbed by the skull and soft tissues, and a deep
detector measures light absorbed by an area in the frontal cortex in
the light path. The total and oxygenated hemoglobin concentra-
tions are measured, and this information is entered into an algo-
rithm which assumes that 25% of the blood volume is arterial and
75% is venous; percentage cerebral SO2 is displayed as a result. In
addition, an index of total hemoglobin concentration is displayed,
which can be used as a surrogate measure of relative cerebral
blood volume (CBVI) if hemoglobin remains constant. The sensor
was applied to the forehead just to the right of midline.
Pulsed-wave TCD (EME Companion; Nicolet Biomedical Inc,
Madison, Wis) of the right middle cerebral artery was used to
measure CBFV. A 2-MHz probe was placed over the right tem-
poral area or over the anterior fontanelle, and settings were ad-
justed until a maximal antegrade CBFV signal was obtained. The
mean CBFV was displayed and recorded.
For patients undergoing the Norwood operation, bypass was
initiated through an 8F or 10F aortic cannula inserted into the
distal end of a 3 or 3.5 mm polytetrafluoroethylene graft,* with the
proximal end anastomosed into the distal right innominate artery
or proximal right subclavian artery. Monitoring of CBFV during
innominate artery occlusion ensured baseline CBF. The remaining
patients had a polytetrafluoroethylene graft* used for systemic
arterial flow in the case of an undersized ascending aorta or
standard cannulation of the ascending aorta with a 10F cannula if
the vessel was of adequate size. Patients with interrupted aortic
arch had a second arterial cannula placed in the patent ductus
arteriosus to perfuse the lower body. Patients with aortic arch
hypoplasia were perfused with one or two aortic cannulas, depend-
ing on the anatomy and severity of the arch obstruction. Single or
bicaval venous cannulation was used, depending on the nature of
the intracardiac lesions and the size of the patient.
Bypass was instituted at a flow of 150 mL/(kg  min). Phe-
noxybenzamine (0.25 mg/kg) was administered to all patients
undergoing Norwood procedures on initiation of bypass. Phenoxy-
benzamine (0.25-1 mg/kg) or phentolamine hydrochloride (INN
phentolamine, 0.3-1 mg/kg) was administered to all other patients
on bypass to achieve a mean arterial pressure of 30 to 40 mm Hg
at a minimum flow of 150 mL/(kg  min) throughout the duration
of bypass. Extracorporeal cooling to a nasopharyngeal temperature
of 17°C to 22°C was achieved during no less than 20 minutes,
during which time additional dissection of the aorta and brachio-
cephalic vessels was performed. The target hematocrit was 25%
during the period of hypothermia. The pH-stat blood gas strategy
was used during all phases of the bypass period. Blood gas values
were measured every 10 to 20 minutes, and sweep gas flow was
adjusted to achieve target temperature-corrected PCO2 of 30 to 40
mm Hg and pH of 7.40 to 7.50. Inspired carbon dioxide was added
to the sweep gas as necessary to achieve these values. An aortic
*Gore-Tex vascular graft, registered trademark of W.L. Gore & Associates, Inc,
Flagstaff, Ariz.
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crossclamp was placed, and crystalloid cardioplegia was adminis-
tered. For patients undergoing Norwood procedures, a brief period
(10 minutes) of circulatory arrest was used during atrial septec-
tomy. Then RLFP was used for the aortic reconstruction, as
follows. Snares were placed around the bases of the right innom-
inate, left common carotid, and left subclavian arteries and around
the descending thoracic aorta distal to the coarctation. Perfusion
was then instituted through the polytetrafluoroethylene graft to the
cerebral vessels only during the aortic reconstruction. Bypass flow
was adjusted until the CBFV was within 10% of baseline recorded
at full-flow whole-body bypass at 17°C to 22°C. At the completion
of the aortic reconstruction, the aortic cannula was placed in the
neoaorta during a brief period of DHCA (1-2 minutes). DHCA was
not otherwise used for patients undergoing the Norwood procedure
unless the operation was performed for lesions other than HLHS
and considerable intraoperative decisions were being made on the
basis of intracardiac exploration.
For patients undergoing aortic arch advancement, RLFP was
used for the dissection and extensive mobilization of the descend-
ing thoracic aorta after ligation and division of the isthmus to avoid
excessive cerebral perfusion, again with flow adjusted to match
baseline CBFV. This was followed in some cases by a period of 20
to 30 minutes of DHCA during the anastomosis of the aorta. Thus
two additional vessels, the left subclavian artery and left carotid
artery, were perfused during this form of RLFP. In some cases
DHCA for this procedure was completely avoided by performing
the aortic arch advancement with RLFP alone, depending on the
anatomy and at the surgeon’s discretion.
Intracardiac defects were repaired after aortic reconstruction
during hypothermic full-flow cardiopulmonary bypass at a mini-
mum flow of 150 mL/(kg  min). Low-flow full-body bypass or
DHCA was used only when it was not otherwise possible to
achieve a sufficiently bloodless operating field.
The following data were collected: patient age, patient weight,
diagnosis, operation, bypass time, aortic crossclamp time, DHCA
time, and RLFP time. Data on bypass were collected at three
intervals: during full-flow whole-body bypass at deep hypothermic
temperatures (17°C-22°C) immediately before RLFP, during
RLFP at 17°C to 22°C after adjustment of bypass flow rate to
achieve CBFV values within 10% of baseline, and within 5 min-
utes after aortic reconstruction during full-flow bypass to the
whole body at 17°C to 22°C after steady-state cerebral SO2 and
CBFV values were achieved before rewarming. Data collected
included bypass flow rate, cerebral SO2 and CBFV values, mean
pressure in the radial or brachial and umbilical or femoral arteries,
temperature-corrected blood gas values, hematocrit, calculated
base excess, and plasma lactate (available for the final 19 patients
in the study). One-way repeated measures analysis of variance
(SPSS Inc, Chicago, Ill) was used to compare values between the
three time periods. The Bonferroni test was used for post hoc
pairwise comparisons of the changes in parameters during the
three study time periods. Linear regression analysis was used to
correlate bypass flow during RLFP with mean arterial pressure
measured in the radial artery, cerebral SO2, and CBFV. The t test
was used to compare RLFP times, flow rates, and CBFV between
patients who underwent Norwood procedures and those who did
not. Outcome follow-up consisted of a medical record review of all
available information for the following: 30-day postoperative or
in-hospital mortality; late mortality after 30 days, and neurologic
deficits recorded by the patient’s primary cardiologist during post-
operative outpatient clinic visits.
Results
Thirty-four patients were studied between January 2001 and
February 2002. The patient diagnoses and operations are
presented in Table 1. Thirteen patients underwent the Nor-
wood operation, 13 underwent an aortic arch advancement
procedure, and 8 underwent repair of interrupted aortic arch.
Patient demographic characteristics and bypass times are
presented in Table 2. Cerebral SO2 before incision during
steady-state hemodynamics at 36°C to 37°C was 60% 
11%, and mean CBFV was 21  6 cm/s. RLFP times
ranged from 6 to 158 minutes, and DHCA times ranged
from 0 to 66 minutes. Six patients underwent no DHCA.
The period of RLFP did not differ between patients who
underwent Norwood procedures and those who did not
(62  14 minutes vs 43  36 minutes, respectively, P 
.078).
The intraoperative perfusion and cerebral physiologic
monitoring data are presented in Table 3. During RLFP,
mean arterial pressure in the umbilical or femoral artery
ranged from 4 to 21 mm Hg. The mean bypass flow rate
necessary to maintain baseline CBFV was 63 mL/(kg 
min), with a range of 24 to 94 mL/(kg  min). This
represents a mean of 42% of normal full-flow bypass. The
RLFP flow rate of patients who underwent Norwood pro-
cedures was not different from that of those who did not
(59  18 vs 66  19 mL/[kg  min], respectively, P 
.329). This flow rate had a poor correlation with pressure
measured in the radial or brachial artery (r2  0.006 by
linear regression analysis; Figure 1). Correlations between
RLFP rate and CBFV and between RLFP rate and cerebral
SO2 are presented in Figure 2. Both the calculated base
deficit and the lactate concentration increased during the
RLFP period. CBFV during RLFP did not differ for patients
perfused through the innominate artery only with brachio-
cephalic vessel snares in place with the aortic arch opened
(Norwood and Damus-Kaye-Stansel procedures) and those
perfused through the intact aortic arch for arch advancement
(23  9 vs 22  9 cm/s, respectively, P  .55).
The 30-day postoperative mortality was 1 of 34 patients,
or 2.9%. One patient died on postoperative day 1, a neonate
with Shone complex variant with hypoplastic aortic valve
and ascending aorta and severe endocardial fibroelastosis of
the left ventricle. He underwent the Norwood operation, had
low cardiac output syndrome develop that was unresponsive
to escalating inotropic therapy, and died after a probable
pulmonary hypertensive crisis during weaning from inhaled
nitric oxide. Late mortality after 30 days has consisted of 1
patient who had undergone a Norwood operation for HLHS
who died at the age of 4 months after admission to the
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hospital for pneumonia. He had a cardiac arrest while on the
ward and could not be resuscitated.
Neurologic follow-up has ranged from 1 to 11 months.
One patient who had undergone complete repair of truncus
arteriosus type III with interrupted aortic arch type A was
admitted to the hospital at age the of 3 months with respi-
ratory failure secondary to pneumonia and seizures. Sei-
zures were secondary to a serum sodium concentration of
125 mmol/L from severe dehydration secondary to pyloric
stenosis. The patient returned to baseline neurologic status
without lateralizing findings and has had no further neuro-
logic events. No other survivors had any abnormalities
detected by standard clinical neurologic examination.
Discussion
RLFP is a modified perfusion technique that provides con-
tinuous cerebral perfusion during neonatal aortic arch re-
construction, minimizing or avoiding DHCA. NIRS has
been described as a method to guide bypass flow.6 In this
study we demonstrated that CBFV measurement provides
additional information during RLFP to ensure adequate, but
not excessive, CBF.
Although measurement of cerebral SO2 is a useful trend
monitor, NIRS has shortcomings that make it important to
have an independent, corroborating method to guide bypass
flow during RLFP. First, clinically available NIRS monitors
are unable to measure absolute cerebral SO2, because this
TABLE 1. Patient diagnoses and operations (n  34)
Diagnosis Secondary diagnosis Operation Additional procedures
HLHS (n  12) Norwood operation
Shone complex with LV
endocardial
fibroelastosis (n  1)
Norwood operation
IAA (n  8) Repair IAA
Type A: D-TGA, DORV Arterial switch, repair DORV
Type A: multiple VSDs PA banding
Type A: DORV PA banding
Type A: VSD VSD closure
Type B: unbalanced CAVC, AS Damus-Kaye-Stansel
procedure
Type B: VSD, subaortic stenosis Subaortic resection, VSD closure
Type B: AP window, ASD AP window, ASD
Type B: truncus type III, ASD Rastelli repair of truncus
Transverse aortic arch
hypoplasia (n  13)
Aortic arch advancement
CoA, AS, multiple VSDs Aortic valvotomy, PA banding




CoA, VSD PA banding
Shone variant—CoA, VSD VSD repair
D-TGA, VSD, CoA, ASD, PDA Arterial switch; VSD, ASD,
and PDA repair; RVOT
resection
Shone variant—hypoplastic MV,




DORV, mitral stenosis, ASD Atrial septectomy, PA band
Severe aortic arch stenosis and
aneurysm
None
Severe aortic arch hypoplasia with
near interruption, large PDA
PDA ligation
D-TGA, mitral atresia, LV
hypoplasia, CoA PDA, PFO
PA band, atrial septectomy,
PDA ligation
Dextrocardia, single ventricle,
subaortic stenosis, AS, CoA
PA band, subaortic resection,
atrial septectomy
Shone variant-hypoplastic LV, MV Inspect MV
LV, Left ventricle; IAA, interrupted aortic arch; D-TGA, dextrotransposition of the great arteries; DORV, double-outlet right ventricle; VSD, ventricular septal
defect; PA, pulmonary artery; CAVC, complete atrioventricular canal; AS, aortic stenosis; AP, aortopulmonary; ASD, atrial septal defect; CoA, coarctation
of aorta; PDA, patent ductus arteriosus; RVOT, right ventricular outflow tract; PDA, patent ductus arteriosus; MV, mitral valve; AV, aortic valve; PFO, patent
foramen ovale.
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would require measurement of the path length of the ab-
sorbed infrared light,13 which is not available on the Soma-
netics INVOS 5100 or the NIRO 500 NIRS monitor
(Hamamatsu Photonics KK, Hananatsu City, Japan) used in
previous descriptions of NIRS for RLFP.6,14 Second, cere-
bral SO2 measurement by NIRS depends on an algorithm
assuming that 75% of the cerebral blood volume is venous
blood and 25% is arterial. This assumption is based on adult
data, does not account for patient variability, and has not
been verified for pediatric patients. Finally, the Somanetics
monitor displays a maximal cerebral SO2 of 95%. Many
patients have extremely high cerebral SO2 values during
hypothermic bypass. Under these conditions the Somanetics
NIRS monitor would only detect inadequate blood flow
(desaturation) and not excessive CBF (hypersaturation).
Fourteen of our 34 patients had a cerebral SO2 reading of
95% during RLFP, potentially leaving them vulnerable to
overcirculation. Six of these patients underwent perfusion to
the innominate artery alone with the aortic arch opened and
brachiocephalic vessel snares in place, and the other 8
underwent perfusion with the aortic arch intact. The poten-
tial dangers of excessive CBF during RLFP include cerebral
edema and intracranial hemorrhage. Although there have
been no reports of these complications from hypothermic
bypass during cardiac surgery in neonates, even in prema-
ture infants,15 intracranial hemorrhage occurs frequently
during extracorporeal membrane oxygenation for neonatal
respiratory and cardiac failure.16 This complication is asso-
ciated with the use of high extracorporeal membrane oxy-
genation flows accompanied by elevated mean arterial pres-
sure, and TCD has been used to demonstrate excessive CBF
under these conditions.17 Data from our study demonstrate
that measurement of mean arterial pressure alone may be
insufficient to protect against this potential problem. Newly
available NIRS monitors (NIRO 300; Hamamatsu Photon-
ics) that use four infrared wavelengths and specially re-
solved spectrometer technology13 and prototype frequency
domain NIRS devices18 have the potential to accurately
measure an absolute value for cerebral SO2.
Compared with jugular venous bulb blood SO2, the NIRS
values tend to run high at low jugular venous bulb SO2 and
low at high jugular venous bulb SO2 in children undergoing
operations for congenital heart defects.9 This could lead to
a situation during RLFP where bypass flow is unnecessarily
increased to achieve a higher NIRS reading of cerebral SO2.
Finally, the NIRS device only measures cerebral SO2 in a
small volume of frontal cerebral cortex in the path of the
emitted infrared light, leaving other areas of the brain po-
tentially vulnerable.
CBFV, as measured by TCD, also has its own limita-
tions. TCD measures CBFV only and does not provide a
Figure 1. Mean arterial pressure during RLFP measured in radial or brachial artery versus cardiopulmonary bypass
(CPB) flow rate necessary to achieve baseline cerebral SO2 and TCD CBFV; r
2 0.006 by linear regression analysis.
TABLE 2. Patient demographic and cardiopulmonary by-
pass data (n  34)
Mean  SD Range
Weight (kg) 3.2 0.7 2.0-5.8
Age (d) 13 23 2-128
Cardiopulmonary bypass time (min) 180 68 69-348
Aortic crossclamp time (min) 94 44 0-239
DHCA time (min) 19 16 0-66
RLFP time (min) 50 31 6-158
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direct measure of blood flow. However, CBFV is directly
proportional to total blood flow if cerebral vascular resis-
tance and perfusion pressure are constant. These conditions
were met during the hypothermic bypass data collection
phase of this study. TCD also measures flow in only one
cerebral artery and thus could potentially leave hypoperfu-
sion undetected in other areas of the brain.
In addition to cerebral SO2, the Somanetics cerebral
oximeter can display a relative CBVI. This is an index that
reflects total cerebral intravascular hemoglobin, as deter-
mined by the change in absorbence at 810 nm, which is the
isosbestic point for oxygenated and deoxygenated hemoglo-
bin.19 Pigula and colleagues6 have described the use of
CBVI along with cerebral SO2 to guide bypass flow during
RLFP. CBVI may reflect actual cerebral blood volume only
if hemoglobin concentration does not change; however,
there has been no reported validation of this measurement.
In addition, the CBVI is displayed as an index without a
numeric readout on a scale that is difficult to read because
of its small size. For these reasons we did not attempt to
Figure 2. Mean CBFV (on left axis, filled circles) and cerebral SO2 (ScO2) (on right axis, open circles) versus RLFP
flow rate; r2 values for linear regression analysis are displayed.







Mean arterial pressure, radial/brachial
artery (mm Hg)
34 4 29 8* 34 5
Mean arterial pressure, umbilical/femoral
artery (mm Hg)
31 6 12 4* 35 5†
Cardiopulmonary bypass flow
(mL/[kg  min])
153 8 63 19* 158 17
CBFV (cm/s) 22 10 22 9 20 8
Cerebral SO2 (%) 87 9 88 8 86 9
Calculated base excess 1.0 3.0 0.1 2.2* 1.5 2.8†
Lactate (mmol/L), n  19 3.0 1.9 3.4 1.8* 4.3 1.6†
Hematocrit (%) 25 3 24 3 24 3
pH (temperature corrected) 7.49 0.09 7.52 0.06‡ 7.44 0.09†
PCO2 (temperature corrected) 30 7 26 4* 31 7
Results expressed as mean  SD.
*P  .05 versus baseline and postrepair values, 1-way analysis of variance.
†P  .05 versus baseline value, 1-way analysis of variance.
‡P  .05 versus postrepair value, 1-way analysis of variance.
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correlate CBVI with TCD measurements, and we believe
that the addition of CBFV measurement provides important
additional information during RLFP.
In Pigula and colleagues’ study,6 a bypass flow of only
20 mL/(kgmin) was necessary to restore cerebral SO2 and
CBVI to baseline levels. This contrasts with the average
value of 63 mL/(kg  min) for our patients, with flows as
high as 94 mL/(kg  min). Despite these higher flows, the
surgical field remained bloodless in all patients in our study
during the arch reconstruction. There are several reasons for
this discrepancy. First, Pigula and colleagues6 used the
alpha-stat blood gas management, which may lead to rela-
tively less CBF and volume even at hypothermic tempera-
tures. We used the pH-stat strategy because of recent human
and experimental animal evidence that neurologic outcome
is improved relative to the alpha-stat strategy.20,21 De-
creased cerebral vascular resistance with this strategy may
require higher blood flows and volumes. Second, every
patient in our study received either phenoxybenzamine or
phentolamine hydrochloride, potent -receptor antagonists
that dilate the cerebral vasculature. Third, although our
cannulation technique was identical to that of Pigula and
colleagues6 for patients undergoing the Norwood operation,
19 of our 34 patients underwent aortic arch advancement
without snares on the brachiocephalic vessels or opening of
the proximal aortic arch. The left subclavian artery and left
carotid artery were also perfused during the latter technique,
because the descending aortic crossclamp was applied distal
to them. Therefore in some cases we potentially perfused
additional vascular beds; however, the lack of difference in
RLFP flow between patients who underwent Norwood pro-
cedures and those who did not argues against this. The need
for higher flows during RLFP relative to previous studies is
also consistent with our institutional strategy of high-flow,
low-pressure, vasodilated perfusion throughout cardiopul-
monary bypass because of the theoretic advantages associ-
ated with this practice of improved end-organ function and
less capillary leakage. We also sought to duplicate the
prebypass, steady-state CBFV for each patient. Finally,
although this was not addressed in our study, higher RLFP
rates may provide higher blood flow to the lower body
through collateral circulation, potentially increasing oxygen
delivery to the subdiaphragmatic vascular beds and improv-
ing organ function.
One important finding of our study is that the pressure
measured in the radial or brachial artery during RLFP had
no correlation with the bypass flow required for adequate
cerebral perfusion and oxygenation. Similarly, both cerebral
SO2 and pump flow rate had a poor correlation with the
CBFV during RLFP. Thus increasing bypass flow to a target
pressure, cerebral SO2, or predetermined flow rate, without
another monitor of cerebral perfusion, could lead to inade-
quate or excessive CBF.
We demonstrated, as have Pigula and coworkers,14 that
RLFP results in a significant pressure detected in the um-
bilical or femoral artery. The presumed reason for this
somatic circulatory support during RLFP is the extensive
network of arterial collaterals in the neonate, from vessels
such as the internal thoracic and intercostal arteries that
connect to the arterial supply of the subdiaphragmatic vis-
cera.14 However, our patients had significant increases in
lactate and calculated base deficit during RLFP. This is not
explained by addition of banked blood with elevated lactate
concentration to the bypass circuit, because none of our
patients received additional blood during the period of hy-
pothermia. Thus inadequate oxygen delivery to some tissue
beds of a severity to cause lactic acidosis developed during
RLFP. This would predictably be worse if these vascular
beds were subjected to DHCA.
In conclusion, this study demonstrates that CBFV, as
measured by TCD, is a useful addition to cerebral SO2, as
measured by NIRS, in guiding bypass flow during RLFP.
We did not compare TCD used together with NIRS against
NIRS alone in guiding RLFP and thus did not prove one
method superior to the other; a randomized controlled study
would be necessary to answer that question. TCD provides
information that NIRS alone cannot, specifically an inde-
pendent, validated method of estimating CBF with an easily
readable numeric display and waveform. The addition of
TCD to NIRS monitoring during RLFP may increase the
safety and accuracy of this technique by avoiding excessive
CBF.
We thank Debora East, RN, for assistance with data collection,
Barbara Skjonsby, RN, for editorial assistance, and E. O’Brian
Smith, PhD, for statistical consultation.
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Discussion
Dr Frank A. Pigula (Pittsburgh, Pa). In this study Andropou-
los and colleagues have evaluated TCD as a means of regulating
RLFP in neonates and infants undergoing arch reconstruction. I
think that this is an interesting study because it expands on the
discussion of the regulation of regional perfusion, which to my
mind is a critical issue in the safe and successful application of this
technique.
In this study data were collected before, during, and after
regional perfusion under similar conditions, with the goal of main-
taining cerebral SO2 and CBFV within 10% of baseline values.
With this approach, Andropoulos and colleagues reported that
regional perfusion was able to maintain measurable blood pres-
sures both above and below the diaphragm while maintaining
cerebral SO2 at baseline levels.
Dr Fraser, your rationale for the use of TCD is that under
hypothermic conditions NIRS may overestimate RLFP require-
ments, leading to cerebral hyperperfusion and brain injury. You
correctly point out that NIRS measures cerebral SO2 only to 95%.
When you used the TCD to guide your regional perfusion rates, 13
of the 34 patients had cerebral SO2 of 95% during RLFP. In relying
on the CBFV to manage regional perfusion rates, more than a third
of your patients were at risk for the complication of concern,
cerebral hyperperfusion.
I have a few questions. First, how did the TCD data alter your
perfusion management? Did you reduce regional perfusion rates
for cerebral SO2 of 95%?
Second, you stated in the article that CBFV and cerebral SO2
were maintained within 10% of baseline values. Which variable
did you consider most important to maintain?
Third, you presumably collected relative blood volume data as
well as SO2 data with NIRS, and it would be of interest to know
what the relative CBVI was for these patients and how it correlated
with the TCD data.
Finally, in the article you stated that CBFV, as measured by
TCD, provides information that NIRS alone cannot. Can you
elaborate and be more specific on the advantages of TCD?
Dr Fraser. Thank you, Dr Pigula. You have certainly been a
leader in the investigation of this methodology, and we took a lot
of our direction from your pioneering work. We are grateful for
your insight into this study.
Our questions actually arose from my concerns about the use of
this technique, having grown up with circulatory arrest as sort of
the standard. I was quite concerned and actually somewhat reluc-
tant to take this on, for the very reasons to which you alluded, that
there is a significant potential for hypercirculation to the brain.
Through the investigation of your work and that of others, we
came to believe that the CBVI, in addition to the NIRS cerebral
SO2 data, was inadequate for us to be sure that we were not
overperfusing the brain.
In a practical sense, we found the CBVI readout on the NIRS
monitor difficult to follow. There are no units associated with it.
As you know, it is not really a Food and Drug Administration-
approved measurement. And we are not really sure what it means,
because it actually can vary somewhat depending on the patient
hematocrit. So to follow the CBVI one must be quite confident that
the hematocrit is staying the same during the whole period. Of
course, it often is during this procedure, but we did not consider it
was sufficiently certain. Because we had been using TCD for other
reasons in our patients, sharing cannula position and venous drain-
age, it seemed like a natural extension for us.
In fact, for those patients you mentioned with NIRS values of
95%, it is hard to know what that means. I think that in those cases
individually we did vary flows on the basis of TCD data, most
commonly to decrease the flow.
Dr Erle H. Austin III (Louisville, Ky). I congratulate you on
your decision to use intraoperative neuromonitoring in this group,
as well as on your excellent clinical results. I would quibble with
you a little bit about the word novel in the title of your article. We
have been using a combination of TCD and NIRS on a routine
basis for infants undergoing heart surgery since 1994, and we
actually reported on our initial experience with its use at this
meeting in 1997.
We believe that both modalities do provide complementary
information that neither technique can provide on its own. We do
use these techniques routinely, and we have also found them useful
in infants who undergo selective antegrade cerebral perfusion for
procedures on the aortic arch, as you have presented here. We have
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had experience with 20 patients during the past 2 years. We use the
TCD to tell us when we have established antegrade cerebral flow
and to warn us when there is too much CBF, as you have done.
In 14 of those 20 patients, we actually detected an abnormality
with the TCD, with the flow being too high, too low, or even
absent. These findings resulted in an alteration in our pump flow or
repositioning of the arterial cannula. In 6 cases with no abnormal-
ity in the TCD flow there was an abnormality or a significant
desaturation found with the NIRS oximeter. In these cases we were
able to correct the abnormality by increasing pump flow or making
some kind of a change in hematocrit or pH. So simply put, our
experience in Louisville in many ways reflects yours and further
supports the value of multimodality intraoperative neurophysio-
logic monitoring in infants undergoing heart surgery.
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